Vivek Subbiah, MD
banner
viveksubbiah.bsky.social
Vivek Subbiah, MD
@viveksubbiah.bsky.social
Early Phase Drug Development; Oncologist; Precision Medicine; Phase 1 trials; AI & Precision Oncology; Clinical trials. Posts=My own
Reposted by Vivek Subbiah, MD
🎙️ @hoperugo.bsky.social of @cityofhope.bsky.social & @viveksubbiah.bsky.social of Sarah Cannon Research Institute discuss innovative trial designs, treatment strategies, and key insights on the future of rare cancer research on the ASCO Education #BytheBook Podcast. url-shortener.me/820P
#ASCOEdBook
January 16, 2026 at 4:15 PM
Reposted by Vivek Subbiah, MD
Reposted by Vivek Subbiah, MD
December 20, 2025 at 8:00 PM
Why cancer can come back years later — and how to stop it www.nature.com/articles/d41...
Why cancer can come back years later — and how to stop it
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
www.nature.com
January 8, 2026 at 3:14 AM
Reposted by Vivek Subbiah, MD
Reposted by Vivek Subbiah, MD
2. Need structured approaches for how to evaluate even when an ultra-specific histology driven approach isn't feasible, as @viveksubbiah.bsky.social outlines for rare cancers here: ascopubs.org/doi/10.1200/...
Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare Cancers | JCO Oncology Practice
ascopubs.org
October 28, 2025 at 1:04 AM
Reposted by Vivek Subbiah, MD
Read the Cancer Discovery Piece: Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine by @viveksubbiah.bsky.social doi.org/10.1158/2159...
Great #ESMO25 talk by @viveksubbiah.bsky.social on targeting molecular drivers of cancer in a tissue-agnostic manner: for more of his thoughts, check out his @aacrjournals.bsky.social Cancer Discovery piece (online as of October 17) here:
October 20, 2025 at 1:37 PM
Reposted by Vivek Subbiah, MD
Great #ESMO25 talk by @viveksubbiah.bsky.social on targeting molecular drivers of cancer in a tissue-agnostic manner: for more of his thoughts, check out his @aacrjournals.bsky.social Cancer Discovery piece (online as of October 17) here:
October 20, 2025 at 6:37 AM
Reposted by Vivek Subbiah, MD
D-7 until #ESMO25! 👋🇩🇪

Excited to be part of first ever tumor-agnostic scientific track with @viveksubbiah.bsky.social @JulianaRBeale #NiamhColeman

Don’t miss these educational sessions! ⬇️ @myesmo.bsky.social
October 10, 2025 at 8:22 AM